{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:17Z","timestamp":1786980257620,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32CA009351-41"],"award-info":[{"award-number":["5T32CA009351-41"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00467-020-04842-7","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T02:03:45Z","timestamp":1609985025000},"page":"2675-2686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3304-7772","authenticated-orcid":false,"given":"Natalie L.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3743-1325","authenticated-orcid":false,"given":"Sangeeta","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"4842_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jpeds.2018.12.023","volume":"208","author":"PG Park","year":"2019","unstructured":"Park PG, Hong CR, Kang E, Park M, Lee H, Kang HJ, Shin HY, Ha I-S, Cheong HI, Yoon HJ (2019) Acute kidney injury in pediatric cancer patients. J Pediatr 208:243\u2013250 e243","journal-title":"J Pediatr"},{"key":"4842_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","volume":"97","author":"AS Levey","year":"2020","unstructured":"Levey AS, Eckardt K-U, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC (2020) Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 97:1117\u20131129","journal-title":"Kidney Int"},{"key":"4842_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","volume":"376","author":"MH Rosner","year":"2017","unstructured":"Rosner MH, Perazella MA (2017) Acute kidney injury in patients with cancer. N Engl J Med 376:1770\u20131781","journal-title":"N Engl J Med"},{"key":"4842_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00134-007-0579-1","volume":"33","author":"M Darmon","year":"2007","unstructured":"Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay \u00c9 (2007) Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 33:765\u2013772","journal-title":"Intensive Care Med"},{"key":"4842_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/MCC.0000000000000450","volume":"23","author":"MH Rosner","year":"2017","unstructured":"Rosner MH, Capasso G, Perazella MA (2017) Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care 23:475\u2013483","journal-title":"Curr Opin Crit Care"},{"key":"4842_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00467-003-1146-9","volume":"18","author":"L Patzer","year":"2003","unstructured":"Patzer L, Kentouche K, Ringelmann F, Misselwitz J (2003) Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 18:623\u2013635","journal-title":"Pediatr Nephrol"},{"key":"4842_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/petr.12483","volume":"19","author":"MS Didsbury","year":"2015","unstructured":"Didsbury MS, Mackie FE, Kennedy SE (2015) A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant 19:460\u2013470","journal-title":"Pediatr Transplant"},{"key":"4842_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/sj.bmt.1701388","volume":"22","author":"J Kist-van Holthe","year":"1998","unstructured":"Kist-van Holthe J, Van Zwet J, Brand R, Van Weel M, Vossen J, Van Der Heijden A (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22:559\u2013564","journal-title":"Bone Marrow Transplant"},{"key":"4842_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6:8\u201314","journal-title":"Clin Kidney J"},{"key":"4842_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572\u20131582","journal-title":"N Engl J Med"},{"key":"4842_CR11","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","volume":"19","author":"TM Gibson","year":"2018","unstructured":"Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A (2018) Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970\u201399: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 19:1590\u20131601","journal-title":"Lancet Oncol"},{"key":"4842_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P (2016) Chronic kidney disease in children. Clin Kidney J 9:583\u2013591","journal-title":"Clin Kidney J"},{"key":"4842_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.juro.2011.03.110","volume":"186","author":"J Lange","year":"2011","unstructured":"Lange J, Peterson SM, Takashima JR, Grigoriev Y, Ritchey ML, Shamberger RC, Beckwith JB, Perlman E, Green DM, Breslow NE (2011) Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol 186:378\u2013386","journal-title":"J Urol"},{"key":"4842_CR14","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S (2016) Renal complications of hematopoietic-cell transplantation. N Engl J Med 374:2256\u20132267","journal-title":"N Engl J Med"},{"key":"4842_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","volume":"39","author":"S Hingorani","year":"2007","unstructured":"Hingorani S, Guthrie K, Schoch G, Weiss N, McDonald G (2007) Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39:223\u2013229","journal-title":"Bone Marrow Transplant"},{"key":"4842_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/ndt\/gfp485","volume":"25","author":"M Ando","year":"2010","unstructured":"Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K (2010) Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 25:278\u2013282","journal-title":"Nephrol Dial Transplant"},{"key":"4842_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/bjc.1992.378","volume":"66","author":"G Levitt","year":"1992","unstructured":"Levitt G, Yeomans E, Mireaux CD, Breatnach F, Kingston J, Pritchard J (1992) Renal size and function after cure of Wilms' tumour. Br J Cancer 66:877\u2013882","journal-title":"Br J Cancer"},{"key":"4842_CR18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/009127009903900504","volume":"39","author":"R Loebstein","year":"1999","unstructured":"Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454\u2013461","journal-title":"J Clin Pharmacol"},{"key":"4842_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/pbc.20858","volume":"48","author":"W St\u00f6hr","year":"2007","unstructured":"St\u00f6hr W, Paulides M, Bielack S, J\u00fcrgens H, Treuner J, Rossi R, Langer T, Beck J (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48:447\u2013452","journal-title":"Pediatr Blood Cancer"},{"key":"4842_CR20","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1200\/JCO.2008.17.5257","volume":"27","author":"O Oberlin","year":"2009","unstructured":"Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, Bergeron C, Defachelles AS, Gentet J-C, Schmitt C (2009) Long-term evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 27:5350\u20135355","journal-title":"J Clin Oncol"},{"key":"4842_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s004670050585","volume":"13","author":"R Rossi","year":"1999","unstructured":"Rossi R, Kleta R, Ehrich JH (1999) Renal involvement in children with malignancies. Pediatr Nephrol 13:153\u2013162","journal-title":"Pediatr Nephrol"},{"key":"4842_CR22","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/pbc.24545","volume":"60","author":"DA Cozzi","year":"2013","unstructured":"Cozzi DA, Ceccanti S, Frediani S, Mele E, Cozzi F (2013) Renal function adaptation up to the fifth decade after treatment of children with unilateral renal tumor: a cross-sectional and longitudinal study. Pediatr Blood Cancer 60:1534\u20131538","journal-title":"Pediatr Blood Cancer"},{"key":"4842_CR23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjc.6600608","volume":"87","author":"S Bailey","year":"2002","unstructured":"Bailey S, Roberts A, Brock C, Price L, Craft A, Kilkarni R, Lee R, Skillen A, Skinner R (2002) Nephrotoxicity in survivors of Wilms' tumours in the North of England. Br J Cancer 87:1092\u20131098","journal-title":"Br J Cancer"},{"key":"4842_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0022-3476(86)80781-8","volume":"108","author":"TR Welch","year":"1986","unstructured":"Welch TR, McAdams AJ (1986) Focal glomerulosclerosis as a late sequela of Wilms tumor. J Pediatr 108:105\u2013109","journal-title":"J Pediatr"},{"key":"4842_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.2215\/CJN.09980912","volume":"8","author":"IA Dekkers","year":"2013","unstructured":"Dekkers IA, Blijdorp K, Cransberg K, Pluijm SM, Pieters R, Neggers SJ, van den Heuvel-Eibrink MM (2013) Long-term nephrotoxicity in adult survivors of childhood cancer. Clin J Am Soc Nephrol 8:922\u2013929","journal-title":"Clin J Am Soc Nephrol"},{"key":"4842_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2215\/CJN.09620911","volume":"7","author":"SL Knijnenburg","year":"2012","unstructured":"Knijnenburg SL, Jaspers MW, van der Pal HJ, Schouten-van Meeteren AY, Bouts AH, Lieverst JA, B\u00f6kenkamp A, Koning CC, Oldenburger F, Wilde JC (2012) Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. Clin J Am Soc Nephrol 7:1416\u20131427","journal-title":"Clin J Am Soc Nephrol"},{"key":"4842_CR27","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1097\/01.ju.0000176800.00994.3a","volume":"174","author":"NE Breslow","year":"2005","unstructured":"Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM (2005) End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174:1972\u20131975","journal-title":"J Urol"},{"key":"4842_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/(SICI)1096-911X(199602)26:2<75::AID-MPO1>3.0.CO;2-R","volume":"26","author":"ML Ritchey","year":"1996","unstructured":"Ritchey ML, Green DM, Thomas PR, Smith GR, Haase G, Shochat S, Moksness J, Breslow NE (1996) Renal failure in Wilms\u2019 tumor patients: a report from the National Wilms' Tumor Study Group. Med Pediatr Oncol 26:75\u201380","journal-title":"Med Pediatr Oncol"},{"key":"4842_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1681\/ASN.2006020118","volume":"17","author":"S Hingorani","year":"2006","unstructured":"Hingorani S (2006) Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 17:1995\u20132005","journal-title":"J Am Soc Nephrol"},{"key":"4842_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbmt.2007.11.008","volume":"14","author":"S Hingorani","year":"2008","unstructured":"Hingorani S (2008) Chronic kidney disease after pediatric hematopoietic cell transplant. Biol Blood Marrow Transplant 14:84\u201387","journal-title":"Biol Blood Marrow Transplant"},{"key":"4842_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/ndt\/gfp529","volume":"25","author":"M Touzot","year":"2010","unstructured":"Touzot M, Elie C, van Massenhove J, Maillard N, Buzyn A, Fakhouri F (2010) Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study. Nephrol Dial Transplant 25:624\u2013627","journal-title":"Nephrol Dial Transplant"},{"key":"4842_CR32","unstructured":"Children\u2019s Oncology Group (2018) Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. Monrovia, CA, www.survivorshipguidelines.org"},{"key":"4842_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/CAD.0000000000000243","volume":"26","author":"JC Kuo","year":"2015","unstructured":"Kuo JC, Craft PS (2015) Administration of chemotherapy in patients on dialysis. Anticancer Drugs 26:779\u2013784","journal-title":"Anticancer Drugs"},{"key":"4842_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.02780312","volume":"7","author":"MA Perazella","year":"2012","unstructured":"Perazella MA (2012) Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 7:1713\u20131721","journal-title":"Clin J Am Soc Nephrol"},{"key":"4842_CR35","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1097\/MD.0000000000001413","volume":"94","author":"CA Jim\u00e9nez-Triana","year":"2015","unstructured":"Jim\u00e9nez-Triana CA, Castel\u00e1n-Mart\u00ednez OD, Rivas-Ruiz R, Jim\u00e9nez-M\u00e9ndez R, Medina A, Clark P, Rassekh R, Casta\u00f1eda-Hern\u00e1ndez G, Carleton B, Medeiros M, Canadian Pharmacogenomics Network for Drug Safety Consortium (2015) Cisplatin nephrotoxicity and longitudinal growth in children with solid tumors: a retrospective cohort study. Medicine 94:e1413","journal-title":"Medicine"},{"key":"4842_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000168288","volume":"11","author":"MG Bianchetti","year":"1991","unstructured":"Bianchetti MG, Kanaka C, Ridolfi-L\u00fcthy A, Hirt A, Wagner HP, Oetliker OH (1991) Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol 11:127\u2013130","journal-title":"Am J Nephrol"},{"key":"4842_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/pbc.20812","volume":"48","author":"W St\u00f6hr","year":"2007","unstructured":"St\u00f6hr W, Paulides M, Bielack S, J\u00fcrgens H, Koscielniak E, Rossi R, Langer T, Beck J (2007) Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Pediatr Blood Cancer 48:140\u2013147","journal-title":"Pediatr Blood Cancer"},{"key":"4842_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/bjc.1989.233","volume":"60","author":"D Sleijfer","year":"1989","unstructured":"Sleijfer D, Smit E, Meijer S, Mulder N, Postmus P (1989) Acute and cumulative effects of carboplatin on renal function. Br J Cancer 60:116\u2013120","journal-title":"Br J Cancer"},{"key":"4842_CR39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/mpo.10293","volume":"40","author":"L Hempel","year":"2003","unstructured":"Hempel L, Misselwitz J, Fleck C, Kentouche K, Leder C, Appenroth D, Rost M, Zintl F (2003) Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol 40:348\u2013354","journal-title":"Med Pediatr Oncol"},{"key":"4842_CR40","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.20255","volume":"100","author":"BC Widemann","year":"2004","unstructured":"Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC (2004) High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome. Cancer 100:2222\u20132232","journal-title":"Cancer"},{"key":"4842_CR41","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1054\/bjoc.2000.1214","volume":"82","author":"R Skinner","year":"2000","unstructured":"Skinner R, Cotterill S, Stevens M (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. Br J Cancer 82:1636","journal-title":"Br J Cancer"},{"key":"4842_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1200\/JCO.1994.12.1.159","volume":"12","author":"R Rossi","year":"1994","unstructured":"Rossi R, G\u00f6dde A, Kleinebrand A, Riepenhausen M, Boos J, Ritter J, J\u00fcrgens H (1994) Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 12:159\u2013165","journal-title":"J Clin Oncol"},{"key":"4842_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ki.2015.30","volume":"87","author":"MA Perazella","year":"2015","unstructured":"Perazella MA, Izzedine H (2015) New drug toxicities in the onco-nephrology world. Kidney Int 87:909\u2013917","journal-title":"Kidney Int"},{"key":"4842_CR44","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nrneph.2015.15","volume":"11","author":"C Porta","year":"2015","unstructured":"Porta C, Cosmai L, Gallieni M, Pedrazzoli P, Malberti F (2015) Renal effects of targeted anticancer therapies. Nat Rev Nephrol 11:354\u2013370","journal-title":"Nat Rev Nephrol"},{"key":"4842_CR45","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/cncr.23773","volume":"113","author":"M Choi","year":"2008","unstructured":"Choi M, Sun CL, Kurian S, Carter A, Francisco L, Forman SJ, Bhatia S (2008) Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation. Cancer 113:1580\u20131587","journal-title":"Cancer"},{"key":"4842_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2015.11.008","volume":"72","author":"I Umbro","year":"2016","unstructured":"Umbro I, Gentile G, Tinti F, Muiesan P, Mitterhofer AP (2016) Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury. J Infect 72:131\u2013142","journal-title":"J Infect"},{"key":"4842_CR47","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","volume":"30","author":"T Lehrnbecher","year":"2012","unstructured":"Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL (2012) Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 30:4427\u20134438","journal-title":"J Clin Oncol"},{"key":"4842_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.ajkd.2009.10.048","volume":"55","author":"SM Sutherland","year":"2010","unstructured":"Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM (2010) Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55:316\u2013325","journal-title":"Am J Kidney Dis"},{"key":"4842_CR49","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1097\/CCM.0000000000003973","volume":"47","author":"PA Raymakers-Janssen","year":"2019","unstructured":"Raymakers-Janssen PA, Lilien MR, Tibboel D, Kneyber MC, Dijkstra S, van Woensel JB, Lemson J, Cransberg K, Van Den Heuvel-Eibrink MM, W\u00f6sten-van Asperen RM (2019) Epidemiology and outcome of critically Ill pediatric cancer and hematopoietic stem cell transplant patients requiring continuous renal replacement therapy: a retrospective nationwide cohort study. Crit Care Med 47:e893","journal-title":"Crit Care Med"},{"key":"4842_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcrc.2013.09.008","volume":"29","author":"ED Boschee","year":"2014","unstructured":"Boschee ED, Cave DA, Garros D, Lequier L, Granoski DA, Guerra GG, Ryerson LM (2014) Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care. J Crit Care 29:37\u201342","journal-title":"J Crit Care"},{"key":"4842_CR51","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.bbmt.2012.12.012","volume":"19","author":"JS Rajpal","year":"2013","unstructured":"Rajpal JS, Patel N, Vogel RI, Kashtan CE, Smith AR (2013) Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 19:661\u2013665","journal-title":"Biol Blood Marrow Transplant"},{"key":"4842_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13054-016-1382-6","volume":"20","author":"N Lameire","year":"2016","unstructured":"Lameire N, Vanholder R, Van Biesen W, Benoit D (2016) Acute kidney injury in critically ill cancer patients: an update. Crit Care 20:209","journal-title":"Crit Care"},{"key":"4842_CR53","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/sj.bmt.1703393","volume":"29","author":"B Horn","year":"2002","unstructured":"Horn B, Reiss U, Matthay K, McMillan A, Cowan M (2002) Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma. Bone Marrow Transplant 29:409\u2013415","journal-title":"Bone Marrow Transplant"},{"key":"4842_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S (2010) Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 16:157\u2013168","journal-title":"Biol Blood Marrow Transplant"},{"key":"4842_CR55","doi-asserted-by":"publisher","first-page":"e13139","DOI":"10.1111\/petr.13139","volume":"22","author":"R Raina","year":"2018","unstructured":"Raina R, Abusin GA, Vijayaraghavan P, Auletta JJ, Cabral L, Hashem H, Vogt BA, Cooke KR, Abu-Arja RF (2018) The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation. Pediatr Transplant 22:e13139","journal-title":"Pediatr Transplant"},{"key":"4842_CR56","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J (2014) Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 124:645\u2013653","journal-title":"Blood"},{"key":"4842_CR57","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","volume":"61","author":"A Mii","year":"2011","unstructured":"Mii A, Shimizu A, Kaneko T, Fujita E, Fukui M, Fujino T, Utsumi K, Yamaguchi H, Tajika K, Si T (2011) Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Pathol Int 61:518\u2013527","journal-title":"Pathol Int"},{"key":"4842_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","volume":"22","author":"CF Christiansen","year":"2011","unstructured":"Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, S\u00f8rensen HT (2011) Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med 22:399\u2013406","journal-title":"Eur J Intern Med"},{"key":"4842_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00467-008-0826-x","volume":"24","author":"S Walters","year":"2009","unstructured":"Walters S, Porter C, Brophy PD (2009) Dialysis and pediatric acute kidney injury: choice of renal support modality. Pediatr Nephrol 24:37\u201348","journal-title":"Pediatr Nephrol"},{"key":"4842_CR60","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","volume":"39","author":"E Cohen","year":"2007","unstructured":"Cohen E, Drobyski W, Moulder J (2007) Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 39:571\u2013572","journal-title":"Bone Marrow Transplant"},{"key":"4842_CR61","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/nep.13091","volume":"23","author":"C B\u00e9chade","year":"2018","unstructured":"B\u00e9chade C, Dejardin O, Bara S, Bouvier V, Guizard AV, De Mil R, Troussard X, Launoy G, Lobbedez T (2018) Survival of patients with cancer starting chronic dialysis: Data from kidney and cancer registries in lower Normandy. Nephrology 23:1125\u20131130","journal-title":"Nephrology"},{"key":"4842_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","volume":"354","author":"P Maisonneuve","year":"1999","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolf RA, Jones E, Dsiney AP, Briggs D (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93\u201399","journal-title":"Lancet"},{"key":"4842_CR63","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.V1351279","volume":"13","author":"AG Stack","year":"2002","unstructured":"Stack AG (2002) Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 13:1279\u20131287","journal-title":"J Am Soc Nephrol"},{"key":"4842_CR64","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00467-012-2140-x","volume":"27","author":"Y Grigoriev","year":"2012","unstructured":"Grigoriev Y, Lange J, Peterson SM, Takashima JR, Ritchey ML, Ko D, Feusner JH, Shamberger RC, Green DM, Breslow NE (2012) Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol 27:1325\u20131333","journal-title":"Pediatr Nephrol"},{"key":"4842_CR65","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1046\/j.1523-1755.2002.00630.x","volume":"62","author":"RD Sheth","year":"2002","unstructured":"Sheth RD, Brandt ML, Brewer ED, Nuchtern JG, Kale AS, Goldstein SL (2002) Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Int 62:1864\u20131869","journal-title":"Kidney Int"},{"key":"4842_CR66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ncponc0451","volume":"3","author":"J Bohlius","year":"2006","unstructured":"Bohlius J, Weingart O, Trelle S, Engert A (2006) Cancer-related anemia and recombinant human erythropoietin\u2014an updated overview. Nat Clin Pract Oncol 3:152\u2013164","journal-title":"Nat Clin Pract Oncol"},{"key":"4842_CR67","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","volume":"373","author":"J Bohlius","year":"2009","unstructured":"Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S (2009) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373:1532\u20131542","journal-title":"Lancet"},{"key":"4842_CR68","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/01.LAB.0000090156.94795.48","volume":"83","author":"S Batra","year":"2003","unstructured":"Batra S, Perelman N, Luck LR, Shimada H, Malik P (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477\u20131487","journal-title":"Lab Invest"},{"key":"4842_CR69","first-page":"CD003407","volume":"12","author":"T Tonia","year":"2012","unstructured":"Tonia T, Mettler A, Robert N, Schwarzer G, Seidenfeld J, Weingart O, Hyde C, Engert A, Bohlius J (2012) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev 12:CD003407","journal-title":"Cochrane Database Syst Rev"},{"key":"4842_CR70","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/bloodadvances.2018030387","volume":"3","author":"J Bohlius","year":"2019","unstructured":"Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update. Blood Adv 3:1197\u20131210","journal-title":"Blood Adv"},{"key":"4842_CR71","first-page":"CD009624","volume":"2","author":"R Mhaskar","year":"2016","unstructured":"Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B (2016) The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. Cochrane Database Syst Rev 2:CD009624","journal-title":"Cochrane Database Syst Rev"},{"key":"4842_CR72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/08880018.2011.570857","volume":"28","author":"O Durmaz","year":"2011","unstructured":"Durmaz O, Demirkaya M, Sevinir B (2011) Recombinant human erythropoietin \u03b2: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. Pediatr Hematol Oncol 28:461\u2013468","journal-title":"Pediatr Hematol Oncol"},{"key":"4842_CR73","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1200\/JCO.2005.03.4371","volume":"24","author":"BI Razzouk","year":"2006","unstructured":"Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR (2006) Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol 24:3583\u20133589","journal-title":"J Clin Oncol"},{"key":"4842_CR74","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/mpo.10185","volume":"39","author":"M B\u00fcy\u00fckpamuk\u00e7u","year":"2002","unstructured":"B\u00fcy\u00fckpamuk\u00e7u M, Varan A, Kutluk T, Aky\u00fcz C (2002) Is epoetin alfa a treatment option for chemotherapy-related anemia in children? Med Pediatr Oncol 39:455\u2013458","journal-title":"Med Pediatr Oncol"},{"key":"4842_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pbc.21953","volume":"53","author":"P Marec-Berard","year":"2009","unstructured":"Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I (2009) 2007 Standards, Options, and Recommendations: Use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. Pediatr Blood Cancer 53:7\u201312","journal-title":"Pediatr Blood Cancer"},{"key":"4842_CR76","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ki.2013.528","volume":"86","author":"AD Hazzan","year":"2014","unstructured":"Hazzan AD, Shah HH, Hong S, Sakhiya V, Wanchoo R, Fishbane S (2014) Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer. Kidney Int 86:34\u201339","journal-title":"Kidney Int"},{"key":"4842_CR77","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S1470-2045(19)30418-8","volume":"20","author":"AC Dietz","year":"2019","unstructured":"Dietz AC, Seidel K, Leisenring WM, Mulrooney DA, Tersak JM, Glick RD, Burnweit CA, Green DM, Diller LR, Smith SA (2019) Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol 20:1420\u20131431","journal-title":"Lancet Oncol"},{"key":"4842_CR78","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1097\/TP.0000000000001659","volume":"101","author":"DO Dahle","year":"2017","unstructured":"Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reis\u00e6ter AV, Mj\u00f8en G, Pihlstr\u00f8m HK, N\u00e6ss H, Holdaas H (2017) Association between pretransplant cancer and survival in kidney transplant recipients. Transplantation 101:2599\u20132605","journal-title":"Transplantation"},{"key":"4842_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/TP.0b013e31829854b7","volume":"96","author":"C Brattstr\u00f6m","year":"2013","unstructured":"Brattstr\u00f6m C, Granath F, Edgren G, Smedby KE, Wilczek HE (2013) Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history. Transplantation 96:297\u2013305","journal-title":"Transplantation"},{"key":"4842_CR80","doi-asserted-by":"publisher","first-page":"509","DOI":"10.23876\/j.krcp.19.047","volume":"38","author":"TH Ban","year":"2019","unstructured":"Ban TH, Park WY, Jin K, Han S, Chung BH, Park SC, Choi BS, Park CW, Yun S-S, Kim Y-S (2019) Changing pattern and safety of pretransplant malignancy in kidney transplant recipients. Kidney Res Clin Pract 38:509\u2013516","journal-title":"Kidney Res Clin Pract"},{"key":"4842_CR81","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/TP.0000000000002178","volume":"102","author":"SA Acuna","year":"2018","unstructured":"Acuna SA, Sutradhar R, Kim SJ, Baxter NN (2018) Solid organ transplantation in patients with preexisting malignancies in remission: a propensity score matched cohort study. Transplantation 102:1156\u20131164","journal-title":"Transplantation"},{"key":"4842_CR82","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/TP.0000000000002459","volume":"103","author":"C Unterrainer","year":"2019","unstructured":"Unterrainer C, Opelz G, D\u00f6hler B, S\u00fcsal C (2019) Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival. Transplantation 103:581\u2013587","journal-title":"Transplantation"},{"key":"4842_CR83","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/TP.0b013e3182637078","volume":"94","author":"P Batabyal","year":"2012","unstructured":"Batabyal P, Chapman JR, Wong G, Craig JC, Tong A (2012) Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable? Transplantation 94:703\u2013713","journal-title":"Transplantation"},{"key":"4842_CR84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.23876\/j.krcp.19.112","volume":"38","author":"S-H Lee","year":"2019","unstructured":"Lee S-H (2019) Approach to kidney transplant patients with pre-transplant malignancy. Kidney Res Clin Pract 38:411\u2013413","journal-title":"Kidney Res Clin Pract"},{"key":"4842_CR85","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/TP.0000000000001192","volume":"101","author":"SA Acuna","year":"2017","unstructured":"Acuna SA, Huang JW, Daly C, Shah PS, Kim SJ, Baxter NN (2017) Outcomes of solid organ transplant recipients with preexisting malignancies in remission: a systematic review and meta-analysis. Transplantation 101:471\u2013481","journal-title":"Transplantation"},{"key":"4842_CR86","doi-asserted-by":"crossref","first-page":"e13557","DOI":"10.1111\/petr.13557","volume":"23","author":"OK Serrano","year":"2019","unstructured":"Serrano OK, Gannon A, Olowofela AS, Reddy A, Berglund D, Matas AJ (2019) Long-term outcomes of pediatric kidney transplant recipients with a pretransplant malignancy. Pediatr Transplant 23:e13557","journal-title":"Pediatr Transplant"},{"key":"4842_CR87","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/ndt\/gfz026","volume":"34","author":"B Watschinger","year":"2019","unstructured":"Watschinger B, Budde K, Crespo M, Heemann U, Hilbrands L, Maggiore U, Mariat C, Oberbauer R, Oniscu GC, Peruzzi L (2019) Pre-existing malignancies in renal transplant candidates\u2014time to reconsider waiting times. Nephrol Dial Transplant 34:1292\u20131300","journal-title":"Nephrol Dial Transplant"},{"key":"4842_CR88","first-page":"14","volume":"2","author":"I Penn","year":"1997","unstructured":"Penn I (1997) Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 2:14\u201317","journal-title":"Ann Transplant"},{"key":"4842_CR89","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0041-1345(00)02698-1","volume":"33","author":"JR Chapman","year":"2001","unstructured":"Chapman JR, Sheil AR, Disney AS (2001) Recurrence of cancer after renal transplantation. Transplant Proc 33:1830\u20131831","journal-title":"Transplant Proc"},{"key":"4842_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/00007890-200109271-00003","volume":"1","author":"BL Kasiske","year":"2001","unstructured":"Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR (2001) The evaluation of renal transplant candidates: clinical practice guidelines. Am J Transplant 1:5\u201395","journal-title":"Am J Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04842-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04842-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:12:47Z","timestamp":1697501567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04842-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04842-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}